Pécoul, B <br/><br/>
Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis.  [electronic resource] 

 -  Lancet (London, England)  Oct 1991 
 - 862-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/0140-6736(91)91511-r  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ampicillin--therapeutic use<br/>Child<br/>Child, Preschool<br/>Chloramphenicol--therapeutic use<br/>Drug Resistance, Microbial<br/>Haemophilus Infections--drug therapy<br/>Haemophilus influenzae--drug effects<br/>Humans<br/>Infant<br/>Injections, Intramuscular<br/>Injections, Intravenous<br/>Klebsiella pneumoniae--drug effects<br/>Meningitis, Bacterial--complications<br/>Meningitis, Meningococcal--drug therapy<br/>Meningitis, Pneumococcal--drug therapy<br/>Neisseria meningitidis--drug effects<br/>Nervous System Diseases--etiology<br/>Proteus mirabilis--drug effects<br/>Streptococcus pneumoniae--drug effects<br/>Survival Rate